Danaher is my new latest #1 choice to strike a deal with Oncologie and hopefully maximum royalties can be projected upon CDMO future revenue streams where whatever miniscule float is left can push the pps to levels that will appease all shareholders
McComb used to work on GE side of house and at least all the subsidiaries of Danaher could fit well into PS Targeting ...PALL would be quite busy providing some water filtration on site etc
Still, too much secrecy to push old BOD out and what has the new BODs been promised and hopefully they did not promise to sell out shareholders for some measly $80 buyout
Market Data 
Markets 
AI
